Benlysta 120 mg and 400 mg powder for concentrate for solution for infusion
Product Information *
Company:GlaxoSmithKline (Ireland) Ltd
Status:No Recent Update
Active Ingredients :
This medicinal product is subject to additional monitoring.
*Additional information is available upon request
Legal Category:Product subject to medical prescription which may not be renewed (A)